| Name | eprosartan methanesulfonate |
|---|---|
| Synonyms |
rostan Mesylate, 10 mM in DMSO
rostan Mesylate ((E)-2-Butyl-1-(p-cboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid, monome acide 4-({2-butyl-5-[(1E)-2-carboxy-3-thiophén-2-ylprop-1-én-1-yl]-1H-imidazol-1-yl}méthyl)benzoïque - acide méthanesulfonique (1:1) 2-Thiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (αE)-, methanesulfonate (1:1) (E)-4-((2-butyl-5-(2-cboxy-3-(thiophen-2-yl)prop-1-enyl)-1H-imidazol-1-yl)methyl)benzoic acid (E)-3-[2-Butyl-1-[(4-cboxyphenyl)methyl]-imidazol-5-yl]-2-(2-thienyl methyl)-2-propenoic acid monomethanesulfonate 2-Thiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (αZ)-, methanesulfonate (1:1) Sunitinib and its interMediate Monomethanesulfonate 4-({2-butyl-5-[(1E)-2-cboxy-2-(thiophen-2-ylMethyl)eth-1-en-1-yl]-1H-iMidazol-1-yl}Methyl)benzoic acid rostan mesylate, >= (αE)-α-[[2-Butyl-1-[(4-cboxyphenyl)Methyl]-1H-iMidazol-5-yl]Methylene]-2-thiophenropanoic Acid MonoMethanesulfonate rostan mesylate //BP (E)-4-((2-Butyl-5-(2-cboxy-3-(thiophen-2-yl)prop-1-en-1-yl)-1H-imidazol-1-yl)methyl)benzoic acid compound with methanesulfonic acid (1:1) MFCD08141807 (E)-4-((2-Butyl-5-(2-cboxy-3-(thiophen-2-yl)prop-1-en-1-yl)-1H-imidazol-1-yl)methyl)benzoic acid methanesulfonic acid salt rostan Myslate rostan MesylateQ: What is rostan Mesylate Q: What is the CAS Number of rostan Mesylate Q: What is the storage condition of rostan Mesylate Q: What e the applications of rostan Mesylate rostan Mesylate (SKF-108566J) (E)-α-[[2-Butyl-1-[(4-cboxyphenyl)Methyl]-1H-iMidazol-5-yl]Methylene]-2-thiophenropanoic Acid Methanesulfonate rostan Mesylate (50 mg) ((E)-2-Butyl-1-(p-cboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid, monomethanesulfonate) Eprosartan (mesylate) (αE)-α-[[2-butyl-1-[(4-cboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-Thiophenropanoic acid methanesulfonate (1:1) 4-[[2-butyl-5-(2-cboxy-3-thiophen-2-yl-prop-1-enyl)-imidazol-1-yl]methyl]benzoic acid mesylate ROSTAN MESYLATE Eprosartan Monomethanesulfonate SKF-108566J Teveten 2-Thiophenropanoic acid, α-[[2-butyl-1-[(4-cboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (αE)-, methanesulfonate (1:1) rostanMesylate> 4-({2-Butyl-5-[(1Z)-2-carboxy-3-(2-thienyl)-1-propen-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid methanesulfonate (1:1) 4-({2-Butyl-5-[(1E)-2-carboxy-3-(2-thienyl)-1-propen-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid methanesulfonate (1:1) ostan mesylate 4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid,methanesulfonic acid rostan Methanesulfonate 4-({2-Butyl-5-[(1E)-2-carboxy-3-thiophen-2-ylprop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzolcarbonsäure-methansulfonsäure(1:1) rostan Monomethanesulfonate 4-({2-butyl-5-[(1E)-2-carboxy-3-thiophen-2-ylprop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid methanesulfonate 4-({2-butyl-5-[(1E)-2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid methanesulfonate (1:1) |
| Description | Eprosartan is a nonpeptide angiotensin II receptor antagonist with IC50 of 9.2 and 3.9 nM in rat and human adrenal cortical membranes, respectively. IC50 Value: 9.2 nM(in rat adrenal cortical membranes); 3.9 nM(in human adrenal cortical membranes)Target: Angiotensin Receptor Type-1(AT1)in vitro: Eprosartan mesylate, is one of the highly selective, orally active, non-peptide angiotensin-II-receptor antagonists [1]. In rat and human adrenal cortical membranes, Eprosartan displaced specifically bound [125I]AII with IC50 of 9.2 and 3.9 nM, respectively. Eprosartan also inhibited [125I]AII binding to human liver membranes (IC50 = 1.7 nM) and to rat mesenteric artery membranes (IC50 = 1.5 nM). In rabbit aortic smooth muscle cells, Eprosartan caused a concentration-dependent inhibition of AII-induced increases in intracellular Ca++ levels. In rabbit aortic rings [2].in vivo: Administration of Eprosartan (3-10 mg/kg) intraduodenally or intragastrically to conscious normotensive rats resulted in a dose-dependent inhibition of the pressor response to AII (250 ng/kg, i.v.). At 10 mg/kg, i.d., significant inhibition of the pressor response to AII was observed for 3 hr. In this same rat model, Eprosartan had no effect on base-line pressure or on the pressor response to norepinephrine or vasopressin [2]. Eprosartan is highly effective and safe in lowering blood pressure, notably SBP, in older subjects with mild to moderate hypertension [3]. Treatment with eprosartan in once-daily doses up to 1200 mg alone or in combination with HCTZ was well tolerated, with dizziness and asthenia being the most common side effects [4]. Therapy with eprosartan mesilat was associated with significant hypotensive effect (more evident in patients with high systolic blood pressure), improvement in 24-hour blood pressure profile and quality of life, and lower probability of secondary stroke. Side effects were not observed [5]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.26 g/cm3 |
|---|---|
| Boiling Point | 660.6ºC |
| Melting Point | 248 °C |
| Molecular Formula | C24H28N2O7S2 |
| Molecular Weight | 520.618 |
| Flash Point | 353.3ºC |
| Exact Mass | 520.133789 |
| PSA | 183.41000 |
| LogP | 5.32920 |
| Vapour Pressure | 2.37E-18mmHg at 25°C |
| Storage condition | room temp |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319 |
| Precautionary Statements | P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Phrases | 36/37/38 |
| Safety Phrases | 26 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2934999090 |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |